1. Home
  2. IDYA vs GNL Comparison

IDYA vs GNL Comparison

Compare IDYA & GNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IDYA
  • GNL
  • Stock Information
  • Founded
  • IDYA 2015
  • GNL 2011
  • Country
  • IDYA United States
  • GNL United States
  • Employees
  • IDYA N/A
  • GNL N/A
  • Industry
  • IDYA Biotechnology: Pharmaceutical Preparations
  • GNL Real Estate Investment Trusts
  • Sector
  • IDYA Health Care
  • GNL Real Estate
  • Exchange
  • IDYA Nasdaq
  • GNL Nasdaq
  • Market Cap
  • IDYA 1.9B
  • GNL 1.7B
  • IPO Year
  • IDYA 2019
  • GNL N/A
  • Fundamental
  • Price
  • IDYA $24.27
  • GNL $7.14
  • Analyst Decision
  • IDYA Strong Buy
  • GNL Buy
  • Analyst Count
  • IDYA 13
  • GNL 3
  • Target Price
  • IDYA $50.82
  • GNL $9.00
  • AVG Volume (30 Days)
  • IDYA 1.0M
  • GNL 1.9M
  • Earning Date
  • IDYA 08-05-2025
  • GNL 08-06-2025
  • Dividend Yield
  • IDYA N/A
  • GNL 10.62%
  • EPS Growth
  • IDYA N/A
  • GNL N/A
  • EPS
  • IDYA N/A
  • GNL N/A
  • Revenue
  • IDYA $7,000,000.00
  • GNL $789,545,000.00
  • Revenue This Year
  • IDYA $115.83
  • GNL N/A
  • Revenue Next Year
  • IDYA $252.50
  • GNL N/A
  • P/E Ratio
  • IDYA N/A
  • GNL N/A
  • Revenue Growth
  • IDYA N/A
  • GNL 38.85
  • 52 Week Low
  • IDYA $13.45
  • GNL $6.51
  • 52 Week High
  • IDYA $44.42
  • GNL $9.11
  • Technical
  • Relative Strength Index (RSI)
  • IDYA 63.79
  • GNL 37.89
  • Support Level
  • IDYA $21.33
  • GNL $7.00
  • Resistance Level
  • IDYA $25.54
  • GNL $7.22
  • Average True Range (ATR)
  • IDYA 1.00
  • GNL 0.14
  • MACD
  • IDYA 0.20
  • GNL -0.02
  • Stochastic Oscillator
  • IDYA 70.60
  • GNL 20.15

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

About GNL Global Net Lease Inc.

Global Net Lease Inc is a real estate investment trust that manages a globally diversified portfolio of commercial real estate properties. The company is engaged in the ownership, management, operating, lease, acquisition, investment, and sale of the portfolio assets. Its segments include Industrial & Distribution; Multi-Tenant Retail; Single-Tenant Retail; and office. The company derives maximum revenue from industrial and distribution segment. The company geographically operates in Unites States, United Kingdom, Canada and Europe.

Share on Social Networks: